392 related articles for article (PubMed ID: 15189916)
61. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease.
Anar C; Bicmen C; Yapicioglu S; Unsal I; Halilcolar H; Yilmaz U
New Microbiol; 2010 Apr; 33(2):117-27. PubMed ID: 20518273
[TBL] [Abstract][Full Text] [Related]
62. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
[TBL] [Abstract][Full Text] [Related]
63. Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial.
Nunes MC; Cutland CL; Jones S; Downs S; Weinberg A; Ortiz JR; Neuzil KM; Simões EAF; Klugman KP; Madhi SA
Clin Infect Dis; 2017 Oct; 65(7):1066-1071. PubMed ID: 28575286
[TBL] [Abstract][Full Text] [Related]
64. Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people.
McElhaney JE
Conn Med; 2003 Sep; 67(8):469-74. PubMed ID: 14587126
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients with Asthma or COPD.
Klassing HM; Ruisinger JF; Prohaska ES; Melton BL
J Community Health; 2018 Apr; 43(2):297-303. PubMed ID: 28852915
[TBL] [Abstract][Full Text] [Related]
66. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.
Govaert TM; Thijs CT; Masurel N; Sprenger MJ; Dinant GJ; Knottnerus JA
JAMA; 1994 Dec; 272(21):1661-5. PubMed ID: 7966893
[TBL] [Abstract][Full Text] [Related]
67. Effects of Lactobacillus coryniformis K8 CECT5711 on the immune response to influenza vaccination and the assessment of common respiratory symptoms in elderly subjects: a randomized controlled trial.
Fonollá J; Gracián C; Maldonado-Lobón JA; Romero C; Bédmar A; Carrillo JC; Martín-Castro C; Cabrera AL; García-Curiel JM; Rodríguez C; Sanbonmatsu S; Pérez-Ruiz M; Navarro JM; Olivares M
Eur J Nutr; 2019 Feb; 58(1):83-90. PubMed ID: 29124387
[TBL] [Abstract][Full Text] [Related]
68. Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial.
McElhaney JE; Goel V; Toane B; Hooten J; Shan JJ
J Altern Complement Med; 2006 Mar; 12(2):153-7. PubMed ID: 16566675
[TBL] [Abstract][Full Text] [Related]
69. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study.
Kositanont U; Kanyok R; Wasi C; Wongsurakiat P; Suthamsmai T; Maranetra N
J Med Assoc Thai; 2004 Aug; 87(8):964-9. PubMed ID: 15471303
[TBL] [Abstract][Full Text] [Related]
70. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
[TBL] [Abstract][Full Text] [Related]
71. Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
Mukherjee PK; Esper F; Buchheit K; Arters K; Adkins I; Ghannoum MA; Salata RA
BMC Infect Dis; 2017 Jan; 17(1):74. PubMed ID: 28088167
[TBL] [Abstract][Full Text] [Related]
72. A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale.
Gravenstein S; Dahal R; Gozalo PL; Davidson HE; Han LF; Taljaard M; Mor V
Clin Trials; 2016 Jun; 13(3):264-74. PubMed ID: 26908539
[TBL] [Abstract][Full Text] [Related]
73. Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal.
Newman KL; Stewart LM; Scott EM; Tielsch JM; Englund JA; Khatry SK; Mullany LC; LeClerq SC; Shrestha L; Kuypers JM; Chu HY; Katz J
Vaccine; 2020 Oct; 38(43):6826-6831. PubMed ID: 32814640
[TBL] [Abstract][Full Text] [Related]
74. Changes in COPD mortality rate after amendments to the Preventive Vaccination Law in Japan.
Kiyohara K; Kojimahara N; Sato Y; Yamaguchi N
Eur J Public Health; 2013 Feb; 23(1):133-9. PubMed ID: 22159002
[TBL] [Abstract][Full Text] [Related]
75. Zanamivir versus trivalent split virus influenza vaccine: a pilot randomized trial.
Coleman BL; Fadel SA; Drews SJ; Hatchette TF; McGeer AJ
Influenza Other Respir Viruses; 2015 Mar; 9(2):78-84. PubMed ID: 25557838
[TBL] [Abstract][Full Text] [Related]
76. Socioeconomic impact of influenza on healthy children and their families.
Principi N; Esposito S; Marchisio P; Gasparini R; Crovari P
Pediatr Infect Dis J; 2003 Oct; 22(10 Suppl):S207-10. PubMed ID: 14551476
[TBL] [Abstract][Full Text] [Related]
77. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
King JC; Lichenstein R; Magder LS
Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
[TBL] [Abstract][Full Text] [Related]
78. Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.
Hirsch A; Katz MA; Laufer Peretz A; Greenberg D; Wendlandt R; Shemer Avni Y; Newes-Adeyi G; Gofer I; Leventer-Roberts M; Davidovitch N; Rosenthal A; Gur-Arie R; Hertz T; Glatman-Freedman A; Monto AS; Azziz-Baumgartner E; Ferdinands JM; Martin ET; Malosh RE; Neyra Quijandría JM; Levine M; Campbell W; Balicer R; Thompson MG;
BMC Infect Dis; 2018 Nov; 18(1):550. PubMed ID: 30400834
[TBL] [Abstract][Full Text] [Related]
79. Comparison of incidence and cost of influenza between healthy and high-risk children <60 months old in Thailand, 2011-2015.
Kittikraisak W; Suntarattiwong P; Kanjanapattanakul W; Ditsungnoen D; Klungthong C; Lindblade KA; Fernandez S; Dawood FS; Chotpitayasunondh T; Olsen SJ
PLoS One; 2018; 13(5):e0197207. PubMed ID: 29771945
[TBL] [Abstract][Full Text] [Related]
80. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
Ainslie KEC; Haber M; Orenstein WA
Vaccine; 2019 Mar; 37(14):1987-1993. PubMed ID: 30833155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
